This tool, which measures eosinophil proteins like eosinophil-derived neurotoxin (EDN), has been shown to correlate well with biopsy findings, providing a useful option for follow-up assessments in patients with EoE [68]. This evidence concerns the gene RNASE2 and eosinophilic esophagitis.